ZERIA PHARMCEUTICAL CO., LTD.JP:4559Income statement

Market cap
¥112.2B
P/E ratio
9.8x
2012/032013/032014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
Revenue53,17053,31861,99761,01362,47564,85064,56961,83260,42755,44259,53368,38375,72587,311
Cost of revenue---18,52117,93018,16918,34217,75316,64415,79717,38518,89520,22423,351
Gross profit---42,49144,54546,68146,22744,07943,78339,64542,14849,48955,50163,960
Gross margin (%)---
Operating income ---2,6794,5664,5424,8303,7374,0953,4426,3669,0159,62212,198
Operating expenses ---39,86139,98342,15041,40540,33439,69736,19335,78240,47445,88051,762
Income before tax 4,4174,6776,8042,7704,4514,4385,0893,2963,8793,1755,9367,5798,51312,841
Provision for income taxes---1,2621,7301,3451,3941,7579817911,7471,0661,8132,651
Net income 1,8933,5164,2462,5583,5323,5764,1833,4642,9393,1313,9756,2077,7319,968
Earnings per share69.1987.57115.0148.1566.1566.7380.7269.5662.6267.7287.76140.26175.39225.42
Dividend per share2327293031323434343435404447